Conference abstract · 7 Mar 2016
Conference abstractPublished 2019
Microneedle vaccine technology
Mercer University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Measles is highly contagious disease caused by the single stranded envoloped RNA virus of Paramyxoviridae family. Currently there is a tremendous increase in the measles virus infection in the United states and this can partly be attributed to the non-compliance to the vaccine regimen. Thus there is an increased need to develop the easy to administer vaccine dosage forms which can lead to increased patient compliance. Since children are the primary recepients of the vaccine, we aimed at delivering the vaccine via needle-free routes: buccal and transdermal delivery of vaccine. Introduction: The vaccine was formulated in microparticulate form to extend the shelf life by eliminating the requirement for cold chain facilities for storage and distribution. The buccal route was selected because the oral cavity is rich in dendritic cells similar to the Langerhans cells, type of antigen – presenting cells (APCs) and high density of T lymphocytes and mucosal associated lymphoid tissue like tonsils, salivary glands, Waldeyer’s ring and pharyngeal lymphoid tissue. The vaccine was also delivered via transdermal route as skin is an attractive site for vaccine delivery because of its many resident dendritic cells and efficient drainage to lymph nodes. The antigen will be recognized by immune cells in the oral cavity and the skin and will be processed to produce protective antibodies against the measles virus. Later, whenever the body is exposed to virus, the protective antibodies will be capable of combating the infection. The goal of this study was to explore the potential of delivery of microparticulate measles vaccine via oral dissolving films (ODF) and transdermal laser ablation and to compare the efficacy of vaccine in producing a robust immune response.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 20 Sep 2018
Enhanced immunity in intradermal vaccination by novel hollow microneedles
Commentary · 29 Mar 2023
A Microneedle Based Vaccine Delivery Platform Deliveres Targeted Vaccines to the Skin to Activate Antigen Presenting Cells
Editorial · 2018
Economic Evaluation of Microneedles for Vaccinations
Conference abstract · 24 Aug 2016
Microneedle based transdermal vaccines for infectious diseases and cancer- Are we there yet?
More from this journal
The newest in Journal of Vaccines & Clinical Trials.
Commentary · 28 Dec 2023
Cholera: A Historical Review, Epidemiology and Management
Commentary · 28 Dec 2023
Epidemiology and Global Impact of Dengue: Clinical Presentation and Disease Progression
Commentary · 28 Dec 2023
An Overview on Infectious Diseases: Its Global Impact and Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Clinical Trials
- SubjectPharmaceutical Sciences
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Richard Addo”

